In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

NEW DELHI: As India works towards becoming a $500-billion pharmaceutical powerhouse by 2047, scientists and industry captains are calling for a shift towards cruelty-free, science-driven drug testing ...